The popular Nova launcher is apparently at an end. The last developer and inventor of the app, Kevin Barry, has thrown in the ...

Big Pharma is vacating infectious diseases research to chase more lucrative segments like oncology and diabetes. This has left behind a gaping void. A set of Indian companies are diving in—Wockhardt, ...